Insulet (PODD) Return on Capital Employed Growth (1y) (2012 - 2026)
Insulet (PODD) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.00 |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 888.00 |
| Dec 31, 2025 | 729.00 |
| Sep 30, 2025 | 429.00 |
| Jun 30, 2025 | 437.00 |
| Mar 31, 2025 | 78.00 |
| Dec 31, 2024 | 162.00 |
| Sep 30, 2024 | 556.00 |
| Jun 30, 2024 | 758.00 |
| Mar 31, 2024 | 1,002.00 |
| Dec 31, 2023 | 856.00 |
| Sep 30, 2023 | 341.00 |
| Jun 30, 2023 | -77.00 |
| Mar 31, 2023 | -655.00 |
| Dec 31, 2022 | -498.00 |
| Sep 30, 2022 | -45.00 |
| Jun 30, 2022 | 168.00 |
| Mar 31, 2022 | 440.00 |
| Dec 31, 2021 | 377.00 |
| Sep 30, 2021 | -117.00 |
| Jun 30, 2021 | -214.00 |